PIM
ELOS

Platinum Investment Management’s Syneron Medical Ltd ELOS Stock Holding History

Platinum Investment Management’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-94,330
Closed -$945K – 98
2014
Q3 		$945K Hold
94,330
– – 0.02% 83
2014
Q2 		$973K Hold
94,330
– – 0.02% 82
2014
Q1 		$1.17M Hold
94,330
– – 0.02% 74
2013
Q4 		$1.16M Hold
94,330
– – 0.02% 66
2013
Q3 		$813K Hold
94,330
– – 0.01% 73
2013
Q2 		$820K Buy
+94,330
New +$843K 0.02% 68

Other funds holding ELOS

SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
HC
Hourglass Capital Houston, Texas $480M AUM 32.35% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Platinum Investment Management's ELOS Position: Q4 2014 in Review

Platinum Investment Management sold out of Syneron Medical Ltd (ELOS) in Q4 2014, closing a stake of 94,330 shares — an estimated $945K sold.

Platinum Investment Management first reported a position in ELOS in Q2 2013 and held it in 6 quarters. The position peaked at $1.17M in Q1 2014. 68 funds tracked by Wall St. Rank hold ELOS as of Q4 2014.

  • Platinum Investment Management reported no remaining Syneron Medical Ltd position as of Q4 2014 after selling out during the quarter.
  • Platinum Investment Management sold 94,330 Syneron Medical Ltd shares in Q4 2014, an estimated $945K.
  • Platinum Investment Management first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 6 quarters.
  • Platinum Investment Management's Syneron Medical Ltd position peaked at $1.17M in Q1 2014.
  • 68 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q4 2014.

Based on Platinum Investment Management's 13F filing for Q4 2014, filed 12 Feb 2015.